Bunge Global S.A.
NYSE:BGAgricultural Farm Products
-$3.65 today
- Market cap
- $17.91B
- Beta
- 0.62
- P/E (TTM)
- 31.8
- EPS (TTM)
- $3.54
- Dividend yield
- 2.51%
Volume 1.49M
Average 1.70M
BG Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Bunge Global S.A.NYSE: BG
Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026
Accounts receivables grows, but more slowly than its trailing trend
Q2 FY2026 accounts receivables of $36M rose 38.5% year over year, behind the +184.2% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at -59.7% a year.
Context
- Accounts receivables amounted to 0.7% of revenue in FY2025, up 0.3 pp from a year earlier.
- Accounts receivables increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +38.5% toward the trailing-twelve-month pace of +184.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (469M) USD
- Year-over-year change
- -377.5%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (469M) | -377.5% |
| FY2024 | 2024-12-31 | 169M | -34.0% |
| FY2023 | 2023-12-31 | 256M | +103.6% |
| FY2022 | 2022-12-31 | (7.15B) | -1248.3% |
| FY2021 | 2021-12-31 | (530M) | — |
Accounts Receivables vs competitors
How BG compares with its peers on the latest reported figures
- BG's LTM Jun 2026 accounts receivables of $324M is the 3rd largest of the 6 companies compared; the peer median is $12.58M.
- Its year-over-year change of +184.2% is the 2nd highest of 6, against a peer median of +55.8%.
- Accounts receivables amounts to 0.4% of revenue for BG, versus a peer median of 0.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $427M | -48.2% | — | 0.5% | |
| LTM Feb 2026 | $367.61M | -373.6% | — | 1.0% | |
| LTM Jun 2026 | $324M | +184.2% | -59.7% | 0.4% | |
| LTM Oct 2026 | $56M | +722.2% | — | 0.5% | |
| LTM Jun 2026 | $12.58M | +109.6% | -2.0% | 0.8% | |
| LTM Jun 2026 | $4.52M | +55.8% | — | 0.0% | |
| Peer median (excluding BG) | $12.58M | +55.8% | -2.0% | 0.5% | |
Competitors are the stored peer set for BG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.17B | 1.68B | 2.34B | 1.19B | 843M |
| Depreciation & Amortization | 424M | 408M | 451M | 468M | 703M |
| Deferred Income Tax | (272M) | (119M) | (1M) | (10M) | (62M) |
| Stock-Based Compensation | 61M | 65M | 69M | 65M | 73M |
| Change in Working Capital | (5.01B) | (7.63B) | 673M | 95M | (502M) |
| Accounts Receivables | (530M) | (7.15B) | 256M | 169M | (469M) |
| Inventory | (1.3B) | (269M) | 1.52B | 96M | (700M) |
| Accounts Payables | 1.59B | 0 | 0 | 0 | 0 |
| Other Working Capital | (4.77B) | (212M) | (1.1B) | (170M) | 667M |
| Other Non-Cash Items | (267M) | 46M | (221M) | 94M | (211M) |
| Operating Cash Flow | (2.89B) | (5.55B) | 3.31B | 1.9B | 844M |
| Capital Expenditures | (399M) | (555M) | (1.12B) | (1.38B) | (1.72B) |
| Acquisitions (Net) | 601M | 453M | 34M | 675M | (3.22B) |
| Purchases of Investments | (342M) | (456M) | (133M) | (1.29B) | (3.08B) |
| Sales of Investments | 171M | 326M | 49M | 958M | 2.75B |
| Other Investing Activities | 5.08B | 6.73B | 163M | (86M) | 43M |
| Investing Cash Flow | 5.11B | 6.5B | (1.01B) | (1.11B) | (5.23B) |
| Debt Repayment | (1.1B) | (705M) | 230M | 1.42B | 3.1B |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (100M) | (200M) | (600M) | (1.1B) | (551M) |
| Dividends Paid | (323M) | (349M) | (383M) | (378M) | (459M) |
| Other Financing Activities | (112M) | 485M | (103M) | (28M) | 144M |
| Financing Cash Flow | (1.63B) | (769M) | (856M) | (90M) | 2.23B |
| Effect of Forex Changes | (63M) | 66M | 28M | 9M | (8M) |
| Net Change in Cash | 524M | 247M | 1.47B | 705M | (2.16B) |
| Free Cash Flow | (3.29B) | (6.1B) | 2.19B | 524M | (879M) |
Bunge Global S.A.
NYSE:BG
Intrinsic Alpha fair value
Locked
Current Price
$93.19
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.